OMN6 a novel bioengineered peptide for the treatment of multidrug resistant Gram negative bacteria
Abstract New antimicrobial agents are urgently needed, especially to eliminate multidrug resistant Gram-negative bacteria that stand for most antibiotic-resistant threats. In the following study, we present superior properties of an engineered antimicrobial peptide, OMN6, a 40-amino acid cyclic pept...
Enregistré dans:
Auteurs principaux: | Shira Mandel, Janna Michaeli, Noa Nur, Isabelle Erbetti, Jonathan Zazoun, Livia Ferrari, Antonio Felici, Moshe Cohen-Kutner, Niv Bachnoff |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/83a72ed367e14c80809b6afdced28df3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
New Multidrug Efflux Inhibitors for Gram-Negative Bacteria
par: Robert L. Marshall, et autres
Publié: (2020) -
Bioengineering
Publié: (2014) -
La máxima "Quod omnes tangit": Una aproximación al estado del tema
par: Merello Arecco,Italo
Publié: (2005) -
Prevalence and characterisation of carbapenemase encoding genes in multidrug-resistant Gram-negative bacilli.
par: Sayran Hamad Haji, et autres
Publié: (2021) -
Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens
par: Yves Briers, et autres
Publié: (2014)